down arrow

Guj. Inject(Ker)

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE659F01014
  • NSEID:
  • BSEID: 524238
INR
25.05
-1.05 (-4.02%)
BSENSE

Apr 11, 12:51 PM

BSE+NSE Vol: 1.2 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Gujarat Inject (Kerala) Ltd stock-summary
stock-summary
Gujarat Inject (Kerala) Ltd
Micro Cap
Pharmaceuticals & Drugs
Gujarat Inject Kerala Limited was incorporated in Jan.' 91. In 2004-05, Company started production of I.V. FIuids in April, 2005.
Company Coordinates stock-summary
Company Details
Bldg No XVII/1103 Kanjikode, Sarayu Arcade Satrapadi Palakkad Kerala : 678621
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 4.88 Cr
Number of Shares
48.85 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
31-Mar-2011
48.85
4.88
-14200
10
Unspecified
31-Mar-2011
48.85
4.88
-14200
10
Unspecified
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

None

Highest Public shareholder

Shivlal Kuberbhai Patel (11.95%)

Individual Investors Holdings

85.91%

stock-summary Board of Directors
stock-summary
stock-summary
Management
Designation
Remuneration
Murli Shivshankaran Nair
Whole Time Director & CFO
0
Reena Mahatma
Director
0
Narayansinh Padudansinh Chauhan
Independent Director
0
Gautam Keshavlal Chauhan
Independent Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
3 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 38 Cr (Micro Cap)

stock-summary
P/E

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00